Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 4, 2012, Pages 307-314

  Lindemann, Christina ^a   Langner, Ingo ^a   Kraut, Angela A ^a   Banaschewski, Tobias ^b   Schad Hansjosten, Tanja ^b   Petermann, Ulrike ^c   Petermann, Franz ^c   Schreyer Mehlhop, Ina ^c   Garbe, Edeltraut ^a   Mikolajczyk, Rafael T ^a  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; FEMALE; GERMANY; HEALTH INSURANCE; HUMAN; ICD-10; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHARMACOEPIDEMIOLOGY; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; SCHOOL CHILD;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; GERMANY; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; METHYLPHENIDATE; PREVALENCE; PROPYLAMINES; SEX FACTORS; TIME FACTORS;

EID: 84865204763     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0064     Document Type: Article

References (56)

1. Adler LD, Nierenberg AA: Review of medication adherence in children and adults with ADHD. Postgrad Med 122:184-191, 2010.
2. Ahrens W, Hagemeier C, Mühlbauer B, Pigeot I, Puntmann I, Reineke A, Steinbach M, Timm J: Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study. Pharmacoepidemiol Drug Saf 16:1298-1307, 2007. (Pubitemid 350303442)
3. Banaschewski T, Becker K, Scherag S, Franke B, Coghill D: Molecular genetics of attention-deficit/hyperactivity disorder: An overview. Eur Child Adolesc Psychiatry 19:237-257, 2010.
4. Banaschewski T, Hollis C, Oosterlaan J, Roeyers H, Rubia K, Willcutt E, Taylor E: Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD. Dev Sci 8:132-140, 2005. (Pubitemid 40344681)
5. Baumgaertel A, Wolraich ML, Dietrich M: Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 34:629-638, 1995.
6. Behr S, Andersohn F, Garbe E: Risk of intracerebral hemorrhage associated with phenprocoumon exposure: A nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf 19:722-730, 2010.
7. Bell AS: A critical review of ADHD diagnostic criteria: What to address in the DSM-V. J Atten Disord 15:3-10, 2011.
8. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T: Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 35:343-351, 1996. (Pubitemid 26072292)
9. Biederman J, Faraone SV: Attention-deficit hyperactivity disorder. Lancet 366:237-248, 2005. (Pubitemid 40981053)
10. Biederman J, Petty CR, Evans M, Small J, Faraone SV: How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res 177:299-304, 2010.
11. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL: Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288: 1740-1748, 2002.
12. Dopfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U: How often do children meet ICD-10/DSM-IV criteria of attention deficit-/ hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample - results of the BELLA study. Eur Child Adolesc Psychiatry 17 Suppl 1:59-70, 2008.
13. Faber A, Kalverdijk LJ, de Jong-van den Berg LT, Hugtenburg JG, Minderaa RB, Tobi H: Parents report on stimulant-treated children in the Netherlands: Initiation of treatment and follow-up care. J Child Adolesc Psychopharmacol 16:432-440, 2006. (Pubitemid 44681463)
14. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P: Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323, 2005. (Pubitemid 40798551)
15. Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of followup studies. Psychol Med 36:159-165, 2006. (Pubitemid 43126140)
16. Fulton BD, Scheffler RM, Hinshaw SP, Levine P, Stone S, Brown TT, Modrek S: National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies. Psychiatr Serv 60:1075-1083, 2009.
17. Garbe E, Suling M, Kloss S, Lindemann C, Schmid U: Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 20:258-264, 2011.
18. Gemeinsamer Bundesausschuss. Decision of the Federal Joint Committee (G-BA) concerning a modification of the drug guideline: Appendix III Issue 44 Stimulants [in German]. Dtsch Arztebl 46: A1762, 2011.
19. Gortz-Dorten A, Dopfner M: Attention deficit/hyperactive disorders in children and adolescents as assessed by parents [in German]. Z Kinder Jugendpsychiatr Psychother 37:183-194, 2009.
20. Habel LA, Schaefer CA, Levine P, Bhat AK, Elliott G: Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol 15:62-67, 2005. (Pubitemid 40365915)
21. Huss M, Holling H, Kurth BM, Schlack R: How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry 17 Suppl 1:52-58, 2008.
22. Janhsen K: Pills for Fidgety Philip [in German]. In: GJK Glaeske, ed., GEK-Medication-Report 2007. Analysis results of GEK-data from the years 2005-2006 [in German] St. Augustin: Asgard-Verlag, 2007, pp. 226-44.
23. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, Ustun TB, Zaslavsky AM: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biol Psychiatry 57:1442-1451, 2005. (Pubitemid 40798566)
24. Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, Tannock R, Castellanos FX: The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry 167:14-16, 2010.
25. Koster I, Schubert I, Dopfner M, Adam C, Ihle P, Lehmkuhl G: Children and adolescents with hyperkinetic disorder. Frequency of the claims diagnosis in primary care based on the data of a regional Statutory Health Insurance Sample - Versichertenstichprobe AOK Hessen/KV Hessen (1998-2001) [in German]. Z Kinder Jugendpsychiatr Psychother 32:157-166, 2004.
26. Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E: Incidence of anogenital warts in Germany: A population-based cohort study. BMC Infect Dis 10:360, 2010.
27. Kuntsi J, Wood AC, Rijsdijk F., Johnson KA, Andreou P, Albrecht B, Arias-Vasquez A, Buitelaar JK, McLoughlin G, Rommelse NN, Sergeant JA, Sonuga-Barke EJ, Uebel H, van der Meere JJ, Banaschewski T, Gill M, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Steinhausen HC, Faraone SV, Asherson P: Separation of cognitive impairments in attentiondeficit/ hyperactivity disorder into 2 familial factors. Arch Gen Psychiatry, 67:1159-1167, 2010.
28. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M: Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155:493-498, 1998. (Pubitemid 28207444)
29. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, Nguyen TT, Schafer H, Holmans P, Daly M, Steinhausen HC, Freitag C, Reif A, Renner TJ, Romanos M, Romanos J, Walitza S, Warnke A, Meyer J, Palmason H, Buitelaar J, Vasquez AA, Lambregts-Rommelse N, Gill M, Anney RJ, Langely K, O'Donovan M, Williams N, Owen M, Thapar A, Kent L, Sergeant J, Roeyers H, Mick E, Biederman J, Doyle A, Smalley S, Loo S, Hakonarson H, Elia J, Todorov A, Miranda A, Mulas F, Ebstein RP, Rothenberger A, Banaschewski T, Oades RD, Sonuga-Barke E, McGough J, Nisenbaum L, Middleton F, Hu X, Nelson S: Metaanalysis of genome-wide association studies of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:884-897, 2010.
30. Pigeot I, Ahrens W, Foraita R, Jahn I, Pohlabeln H: Sample selection and outcome evaluation in primary prevention. J Publ Health 15:93-99, 2007. (Pubitemid 46434784)
31. Pigeot I, Ahrens W: Establishment of a pharmacoepidemiological database in Germany: Methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 17:215-223, 2008. (Pubitemid 351404032)
32. Polanczyk G, Caspi A, Houts R, Kollins SH, Rohde LA, Moffitt TE: Implications of extending the ADHD age-of-onset criterion to age 12: Results from a prospectively studied birth cohort. J Am Acad Child Adolesc Psychiatry 49:210-216, 2010.
33. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942-948, 2007. (Pubitemid 46972911)
34. Polanczyk G, Rohde LA: Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry 20:386-392, 2007. (Pubitemid 46889666)
35. Roberts RE, Roberts CR, Chan W: One-year incidence of psychiatric disorders and associated risk factors among adolescents in the community. J Child Psychol Psychiatry 50:405-415, 2009.
36. Rubia K, Smith AB, Brammer MJ, Taylor E: Temporal lobe dysfunction in medication-naive boys with attention-deficit/hyperactivity disorder during attention allocation and its relation to response variability. Biol Psychiatry, 62:999-1006, 2007. (Pubitemid 47562367)
37. Schink T, Behr S, Garbe E: External validation of prescription data of non-steroidal anti-inflammatory drugs using the 'Arzneiverordnungsreport'[in German]. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS), 2009 (abstract).
38. Schlack R, Holling H, Kurth BM, Huss M: The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:827-835, 2007.
39. Schlander M, Schwarz O, Rothenberger A, Roessner V: Tic disorders: Administrative prevalence and co-occurrence with attention-deficit/hyperactivity disorder in a German community sample. Eur Psychiatry 26:370-374, 2011.
40. Schlander M, Schwarz O, Trott GE, Viapiano M, Bonauer N: Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision. Eur Child Adolesc Psychiatry 16:430-438, 2007.
41. Schmidt S, Petermann F: Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD). BMC Psychiatry 9:58, 2009.
42. Schmidt-Troschke SO, Ostermann T, Melcher D, Schuster R, Erben CM, Matthiessen PF: The use of methylphenidate in children: Analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions [in German]. Gesundheitswesen 66:387-392, 2004. (Pubitemid 38886417)
43. Schubert I, Köster I, Adam C, Ihle P, Döpfner M, Lehmkuhl G: Prescriptions of psychotropic drugs for children and adolescents with the indication 'hyperkinetic conduct disorder' [in German]. Z Gesundh Wiss 11:306-324, 2003.
44. Schubert I, Koster I, Lehmkuhl G: The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: A study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007. Dtsch Arztebl Int 107:615-621, 2010
45. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, Clasen L, Evans A, Giedd J, Rapoport JL: Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A, 104:19,649-19,654, 2007.
46. Skounti M, Philalithis A, Galanakis E: Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J Pediatr 166:117-123, 2007. (Pubitemid 46025502)
47. Surman CB, Adamson JJ, Petty C, Biederman J, Kenealy DC, Levine M, Mick E, Faraone SV: Association between attention-deficit/ hyperactivity disorder and sleep impairment in adulthood: Evidence from a large controlled study. J Clin Psychiatry 70:1523-1529, 2009.
48. van den Ban E, Souverein P, Swaab H, van Engeland H, Heerdink R, Egberts T: Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. J Child Adolesc Psychopharmacol 20:55-61, 2010.
49. Visser SN, Bitsko RH, Danielson ML, Perou R, Blumberg SJ: Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007. MMRW Morbid Mortal Wkly Rep 59:1439-1443, 2010.
50. Weiss G, Hechtman L, Milroy T, Perlman T: Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 24:211-220, 1985. (Pubitemid 15100202)
51. Witthö ft J, Koglin U, Petermann F: Comorbidity of aggressive behaviour and ADHD [in German]. Kindh Entwickl 19:218-227, 2010.
52. Wolff C: AKTIV-study: ADHD in children - therapy and treatment situation in Germany in German]. Jahrestagung des BKJPP. 2011. 6-8-2008. (abstract).
53. Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E: Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)-a pharmacoepidemiological and qualitative study. Health Technol Assess 13:1-120, 2009.
54. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.
55. Zhou K, Dempfle A, Rcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX, Doyle A, Ebstein RP, Ekholm J, Forabosco P, Franke B, Freitag C, Friedel S, Gill M, Hebebrand J, Hinney A, Jacob C, Lesch KP, Loo SK, Lopera F, McCracken JT, McGough JJ, Meyer J, Mick E, Miranda A, Muenke M, Mulas F, Nelson SF, Nguyen TT, Oades RD, Ogdie MN, Palacio JD, Pineda D, Reif A, Renner TJ, Roeyers H, Romanos M, Rothenberger A, Schafer H, Sergeant J, Sinke RJ, Smalley SL, Sonuga-Barke E, Steinhausen HC, van der ME, Walitza S, Warnke A, Lewis CM, Faraone SV, Asherson P: Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1392-1398, 2008.
56. Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA: Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull 33:143-147, 1997 (Pubitemid 27184209)